Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10696710 Pharmaceutical targeting of a mammalian cyclic di-nucleotide signaling pathway

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Date of Patent

June 30, 2020

Patent Application Number

16714595

Date Filed

December 13, 2019

Patent Citations

US Patent 10633411 Pharmaceutical targeting of a mammalian cyclic di-nucleotide signaling pathway

US Patent 10508129 Pharmaceutical targeting of a mammalian cyclic di-nucleotide signaling pathway

US Patent 10336786 Pharmaceutical targeting of a mammalian cyclic di-nucleotide signaling pathway

Patent Primary Examiner

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10696710 Pharmaceutical targeting of a mammalian cyclic di-nucleotide signaling pathway

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool